Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Nov;24(11):1164-1166.
doi: 10.3348/kjr.2023.0752.

Uncover This Tech Term: Independent Central Image Reading

Sang Eun Won #  1 , Sinae Kim #  1 , Chong Hyun Suh  2 , Hyo Jung Park  3 , Kyung Won Kim  3
Affiliations
Editorial

Uncover This Tech Term: Independent Central Image Reading

Sang Eun Won et al. Korean J Radiol. 2023 Nov.
No abstract available

Keywords: Adjudicator; Centralized imaging core laboratory; Imaging endpoint; Independent central image reading; Reader.

PubMed Disclaimer

Conflict of interest statement

Chong Hyun Suh, Assistant to the Editor of the Korean Journal of Radiology, was not involved in the editorial evaluation or decision to publish this article. All authors have declared no conflicts of interest.

Figures

Fig. 1
Fig. 1. Independent central image reading process. Independent central image reading typically involves at least two primary independent readers and one adjudicator.
See this image and copyright information in PMC

References

    1. Lee AJ, Suh CH, Kim KW. In: Therapy response imaging in oncology. Nishino M, editor. Cham: Springer International Publishing; 2020. Evolution of clinical trial imaging and co-clinical imaging; pp. 239–253.
    1. United States. Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, Center for Drug Evaluation and Research. Clinical Trial Imaging Endpoint Process Standards: Guidance for Industry. [accessed on July 26, 2023]. Available at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents....
    1. Beaumont H, Iannessi A, Wang Y, Voyton CM, Cillario J, Liu Y. Blinded Independent Central Review (BICR) in new therapeutic lung cancer trials. Cancers (Basel) 2021;13:4533. - PMC - PubMed
    1. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) Eur J Cancer. 2009;45:228–247. - PubMed
    1. Hyung J, Kim I, Kim KP, Ryoo BY, Jeong JH, Kang MJ, et al. Treatment with liposomal urinotecan plus fluorouracil and leucovorin for patients with previously treated metastatic biliary tract cancer: the phase 2b NIFTY randomized clinical trial. J AMA Oncol. 2023;9:692–699. - PMC - PubMed

Publication types